THE LINK ALTERNATIF MBL77 DIARIES

Not all individuals with CLL demand therapy. Even with all new developments, the iwCLL continue to recommends watchful observation for patients with asymptomatic condition.86 This suggestion relies on at the very least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).